BlackRock’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81.4M Sell
471,726
-45,428
-9% -$7.84M ﹤0.01% 2156
2025
Q1
$80.6M Sell
517,154
-136,134
-21% -$21.2M ﹤0.01% 2108
2024
Q4
$89.9M Buy
653,288
+117,184
+22% +$16.1M ﹤0.01% 2115
2024
Q3
$80M Buy
536,104
+130,115
+32% +$19.4M ﹤0.01% 2179
2024
Q2
$55.4M Buy
405,989
+820
+0.2% +$112K ﹤0.01% 2318
2024
Q1
$61.2M Buy
405,169
+56,147
+16% +$8.49M ﹤0.01% 2288
2023
Q4
$44M Buy
349,022
+15,456
+5% +$1.95M ﹤0.01% 2503
2023
Q3
$31.2M Sell
333,566
-27,524
-8% -$2.58M ﹤0.01% 2640
2023
Q2
$32.2M Sell
361,090
-20,009
-5% -$1.79M ﹤0.01% 2688
2023
Q1
$40.9M Sell
381,099
-13,671
-3% -$1.47M ﹤0.01% 2547
2022
Q4
$48.2M Buy
394,770
+21,146
+6% +$2.58M ﹤0.01% 2460
2022
Q3
$38.6M Sell
373,624
-19,536
-5% -$2.02M ﹤0.01% 2622
2022
Q2
$36.5M Sell
393,160
-7,924
-2% -$737K ﹤0.01% 2666
2022
Q1
$47.1M Buy
401,084
+80,988
+25% +$9.5M ﹤0.01% 2586
2021
Q4
$43.1M Sell
320,096
-18,980
-6% -$2.55M ﹤0.01% 2713
2021
Q3
$54M Buy
339,076
+3,315
+1% +$528K ﹤0.01% 2581
2021
Q2
$44.2M Sell
335,761
-124,526
-27% -$16.4M ﹤0.01% 2743
2021
Q1
$59.3M Sell
460,287
-2,376
-0.5% -$306K ﹤0.01% 2479
2020
Q4
$77.2M Buy
462,663
+7,400
+2% +$1.23M ﹤0.01% 2198
2020
Q3
$70.3M Sell
455,263
-28,454
-6% -$4.39M ﹤0.01% 2062
2020
Q2
$71.5M Buy
483,717
+82,938
+21% +$12.3M ﹤0.01% 2034
2020
Q1
$45.1M Sell
400,779
-22,769
-5% -$2.56M ﹤0.01% 2093
2019
Q4
$58.9M Sell
423,548
-30,429
-7% -$4.23M ﹤0.01% 2240
2019
Q3
$43.7M Sell
453,977
-255
-0.1% -$24.6K ﹤0.01% 2361
2019
Q2
$52.3M Buy
454,232
+30,827
+7% +$3.55M ﹤0.01% 2278
2019
Q1
$49.8M Sell
423,405
-22,906
-5% -$2.7M ﹤0.01% 2271
2018
Q4
$28M Sell
446,311
-14,650
-3% -$918K ﹤0.01% 2544
2018
Q3
$32.7M Buy
460,961
+22,172
+5% +$1.57M ﹤0.01% 2587
2018
Q2
$29.2M Buy
438,789
+32,980
+8% +$2.19M ﹤0.01% 2632
2018
Q1
$26.5M Sell
405,809
-25,533
-6% -$1.67M ﹤0.01% 2599
2017
Q4
$17.3M Buy
+431,342
New +$17.3M ﹤0.01% 2832